Tempus AI TEM is leaning into a dual-engine model: a fast-growing Genomics franchise and a scaling data business powered by an expanding AI toolkit. The third quarter of 2025 marked a turn to non-GAAP ...

Tempus AI TEM operates at the intersection of clinical genomics and AI-driven insights. Its testing and data products are gaining traction with providers and biopharma partners. With revenue up ...

Tempus AI hopes to leverage artificial intelligence and its massive data set to improve outcomes for patients. It has partnered with nearly all of the top oncology companies. The company grew its ...

Investing.com - TD Cowen has reiterated its Hold rating on Tempus AI Inc (NASDAQ:TEM) with a price target of $88.00, aligning with the broader analyst consensus of 2.14 (where 1 is Strong Buy and 5 is ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Key attitudes and strategic frameworks for intelligent and successful investors Marguerita is a Certified Financial Planner (CFP), Chartered Retirement Planning Counselor (CRPC), Retirement Income ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Erika Rasure is globally-recognized as a leading consumer economics subject matter expert, ...